Phillips Connect Appoints Mark Wallin as President and General Manager LIC Shares Extend Gains Ahead of Bonus Record Date Stock Up 7 in Three Sessions Astera Labs Shares Surge 32 Following Bullish Analyst Coverage ValueQuests Sameer Shah Advocates Private Equity Approach to Public Markets for LongTerm Alpha GitHubs Reliability Woes May Challenge Microsofts AI Ambitions Amidst Rising Competition Trump Approval Ratings Slip Below 39 in Four of Five Recent Polls TFIN Q1 2026 Earnings Strong EPS Beat Despite Limited Revenue Disclosure Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution Rentokil Initial RTO Q4 2025 Earnings EPS Miss Weighs on Shares as Margins Face Pressure STNG Q1 2026 Earnings EPS Beats Estimates by 166 as Tanker Market Remains Firm Nexa Resources Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction IDN Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat White Mountains Insurance Holds Steady Above 2100 as Modest Gains Persist Kelly Services KELYA Surges 37 as Employment Sector Gains Momentum Bicara Therapeutics BCAX Edges Lower Traders Watch Support Near 2069 AN2 Therapeutics ANTX Rallies 5 as Bulls Test Critical Resistance at 540 PVH Corp PVH Gains 18 as Retail Sector Rebound Continues Key Resistance at 9269 in Sight DAVE Q1 2026 Earnings EPS Beats Estimates by 37 Stock Declines on Lack of Revenue Details ZWS Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency in Water Solutions Sector Pathward Financial CASH Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly DHI Group DHX Q1 2026 Earnings EPS Surges 164 Above Estimates Shares Rise Acacia Research Q1 2026 Earnings EPS Misses Estimates as Revenue Not Reported Shares Edge Higher TOL Q1 2026 Earnings Earnings Beat Expectations as Homebuilder Navigates Market Conditions IBM Surges on 2 Billion Federal Quantum Computing Boost Adds 27 Billion in Market Value ASR Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Weigh United Therapeutics UTHR Holds Steady Above Support Amid Modest Gains